Tag: oligonucleotide synthesis market growth

  • 2024 Oligonucleotide Synthesis Market Outlook: Size, Share, and Key Growth Drivers

    2024 Oligonucleotide Synthesis Market Outlook: Size, Share, and Key Growth Drivers

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Rate is the Oligonucleotide Synthesis Market Anticipated to Experience from 2024-2033?

    In the past few years, the market size for oligonucleotide synthesis has seen significant expansion. It is projected that the market will escalate from $8.85 billion in 2023 to $10.27 billion in 2024, displaying a compound annual growth rate (CAGR) of 16.0%. The development in the historic period can be ascribed to progress in biomedical research, therapeutic advancement, biotechnological innovation, genomic studies, and the rise in DNA technologies.

    In the coming years, the market size for oligonucleotide synthesis is projected to witness speedy expansion. It is anticipated to inflate to $18.67 billion by 2028, with a compound annual growth rate (CAGR) of 16.1%. The projected escalation during the forecast period can be linked to the advent of diagnostic instruments, RNA interference (RNAi) therapies, restorative medicine, nanotechnology application, and gene editing advancements. The forecast period is also expected to see significant trends like targeted drug development, innovative distribution systems, automated synthesis, CRISPR-Cas technology, and Next-Generation Sequencing (NGS).

    Claim Your Free Sample of the Global Oligonucleotide Synthesis Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

    What Are the Significant Influencers of Growth in the oligonucleotide synthesis Market?

    The escalating rates of chronic disease incidents are anticipated to boost future growth for the oligonucleotide synthesis market. Chronic diseases, which extend for a year or longer, demanding persistent medical care and potentially exacerbating over time, are influenced by gene expression targeted by oligonucleotides. The manifestation of chronic diseases can be modified by oligonucleotides by targeting mRNA, pre-mRNA, or non-coding RNA to adjust splicing events, encourage degradation, or disrupt protein translation. For example, records from the Belgium-based International Diabetes Federation showed that in January 2022 the prevalence of diabetes in individuals aged 20-79 was 536.6 million in 2021 and was expected to rise by 12.2% in 2045. Adding to this, the World Health Organization, an agency of the United Nations, stated in September 2022 that out of the global total deaths due to non-communicable diseases (NCDs) or chronic diseases, 41 million were reported annually, accounting for 74%. Among these deaths, 17.9 million were attributed to cardiovascular problems, 9.3 million to cancer, 4.1 million to chronic respiratory complications, and 2.0 million to diabetes. Consequently, the ubiquity of chronic and rare disease occurrences is fueling the expansion of the oligonucleotide synthesis market.

    What Key Segments Define the Oligonucleotide Synthesis Market?

    1) By Type: Custom Oligos, Predesigned Oligos

    2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

    3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

    What Are the Key Developments Shaping the Oligonucleotide Synthesis Market?

    The oligonucleotide synthesis market is experiencing an increasing trend towards product innovation. To maintain their market standing, key companies in this sector are driving their efforts towards the creation of groundbreaking products. Take, for instance, the DNA Script’s launch of Syntax in July 2021. A French company that specializes in DNA synthesis, DNA Script introduced Syntax, a desktop DNA printer, aimed at genomics and molecular biology applications. The printer, which is powered by DNA Script’s enzymatic DNA synthesis (EDS) technology, allows for the on-site production of DNA oligonucleotides (oligos), essential for genomics workflow. Syntax, as a system, is composed of a desktop DNA printer, consumable and reagent kits, and management software. The start-up time for Syntax is under 15 minutes, and it can produce 20 meters in as little as six hours, and up to 60 meters in a mere 13 hours. Upon completion of synthesis, the printer performs purification, quantification, and normalization of the oligos, making them ready for utilization in the subsequent phase of the research process.

    Order Now for Fast Delivery of Your Oligonucleotide Synthesis Market Report!

    https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

    What Regions Are Driving Expansion in the Oligonucleotide Synthesis Market?

    North America was the largest region in the oligonucleotide synthesis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Oligonucleotide Synthesis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oligonucleotide synthesis market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Oligonucleotide Synthesis Market Include

    1. Oligonucleotide Synthesis Market Executive Summary

    2. Oligonucleotide Synthesis Market Segments

    3. Oligonucleotide Synthesis Market Size And Template Market Growth Rate

    4. Key Oligonucleotide Synthesis Market Trends

    5. Major Oligonucleotide Synthesis Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Oligonucleotide Synthesis Market

    26. Top Oligonucleotide Synthesis Companies

    27. Oligonucleotide Synthesis Market Opportunities And Strategies

    28. Oligonucleotide Synthesis Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Oligonucleotide Therapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

    Oligonucleotide Synthesis Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

    Oil And Gas Upstream Activities Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/oil-and-gas-upstream-activities-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How Is The Oligonucleotide Synthesis Market Expected To Grow Through 2024-2033

    How Is The Oligonucleotide Synthesis Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Oligonucleotide Synthesis Global Market Report 2024, the oligonucleotide synthesis market is expected to show promising growth in the forecast period.

    The oligonucleotide synthesis market has witnessed remarkable growth in recent years, with projections indicating a continued upward trajectory. Key factors driving this expansion include:

    1. Biomedical Research Advancements
    • Progress in biomedical research fuels the demand for oligonucleotide synthesis.
    • Oligonucleotides serve as crucial tools in various research applications, contributing to market growth.
    1. Therapeutic Development
    • Oligonucleotides play a vital role in therapeutic development, particularly in the field of precision medicine.
    • Advancements in oligonucleotide-based therapies drive market expansion, catering to unmet medical needs.
    1. Biotechnology Innovations
    • Continuous innovation in biotechnology enhances the efficiency and applicability of oligonucleotide synthesis techniques.
    • Emerging technologies empower researchers and clinicians, driving the adoption of oligonucleotide-based solutions.
    1. Genomic Studies
    • The surge in genomic studies necessitates high-quality oligonucleotides for various applications, including sequencing and gene editing.
    • Oligonucleotide synthesis market growth aligns with the expanding scope of genomic research initiatives.

    View More On The Oligonucleotide Synthesis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

    The Oligonucleotide Synthesis Market Set To Expand With The Rising Prevalence Of Chronic Diseases

    Understanding the Impact of Chronic Diseases

    The prevalence of chronic diseases emerges as a significant driver for the oligonucleotide synthesis market. Key insights include:

    1. Targeting Chronic Disease Mechanisms
    • Oligonucleotides offer versatile mechanisms to target gene expression underlying chronic diseases.
    • Applications range from modulating splicing events to interfering with protein translation, addressing diverse therapeutic targets.
    1. Statistical Insights
    • Statistical data underscores the global burden of chronic diseases, highlighting the urgent need for effective interventions.
    • Rising prevalence rates, particularly in diseases like diabetes, drive the demand for innovative therapeutic approaches.

    Companies Introducing Innovative Solutions To Pioneer Innovation In The Oligonucleotide Synthesis Market

    Exploring Product Innovation Trends

    Product innovation emerges as a prominent trend shaping the oligonucleotide synthesis market landscape. Noteworthy developments include:

    1. Revolutionary Solutions
    • Companies focus on introducing novel platforms and technologies to enhance oligonucleotide synthesis capabilities.
    • Innovations like DNA Script’s Syntax redefine molecular biology workflows, offering unprecedented speed and efficiency.
    1. Strategic Acquisitions
    • Strategic acquisitions bolster companies’ portfolios and expand their market reach.
    • Biotage’s acquisition of ATDBio exemplifies efforts to strengthen offerings in oligonucleotide synthesis and related applications.

    Segmentation of the Oligonucleotide Synthesis Market

    Understanding Market Dynamics Through Segmentation

    The oligonucleotide synthesis market exhibits diverse characteristics, as highlighted by its segmentation:

    1. Type Segmentation
    • Custom and predesigned oligos cater to distinct research and therapeutic needs.
    • Flexible offerings accommodate varied preferences and applications across the market.
    1. Product Type Diversity
    • Oligonucleotides, reagents, equipment, and services form integral components of the market landscape.
    • Diverse product categories address the evolving requirements of researchers and industry stakeholders.
    1. Application Spectrum
    • Therapeutic, research, and diagnostic applications drive demand across diverse end-user segments.
    • Oligonucleotide-based solutions find utility in a wide range of medical and scientific disciplines.

    Conclusion

    The oligonucleotide synthesis market’s robust growth trajectory reflects its pivotal role in advancing biomedical research and therapeutic development. As companies continue to innovate and expand their offerings, the market is poised for sustained expansion, driven by the increasing prevalence of chronic diseases and the emergence of transformative technologies. With a focus on product innovation, strategic partnerships, and market segmentation, stakeholders are well-positioned to capitalize on the burgeoning opportunities in this dynamic industry landscape.

    Request A Sample Of The Global Oligonucleotide Synthesis Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12176&type=smp